sulforaphane has been researched along with Ovarian Neoplasms in 10 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Higher c-Myb levels in patients with ovarian cancer lead to poor survival and our results indicate a possible effect of dietary factors EGCG and sulforaphane against c-Myb-mediated ovarian cancer progression and chemoresistance." | 1.51 | Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. ( Li, J; Qiao, X; Tian, D; Tian, M; Zhang, L, 2019) |
| "Ovarian cancer is currently the most life‑threatening type of gynecological malignancy with limited treatment options." | 1.48 | Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer. ( Kan, SF; Sun, GX; Wang, J, 2018) |
| "Sulforaphane (SFN) is a major ITC present in broccoli." | 1.34 | Sulforaphane induces growth arrest and apoptosis in human ovarian cancer cells. ( Chiao, JW; Chuang, LT; Gretz, HF; Moqattash, ST; Nezhat, F; Rahaman, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, TT | 1 |
| Liu, XD | 1 |
| Zhan, ZP | 1 |
| Wu, QJ | 1 |
| Kan, SF | 1 |
| Wang, J | 1 |
| Sun, GX | 1 |
| Tian, M | 1 |
| Tian, D | 1 |
| Qiao, X | 1 |
| Li, J | 1 |
| Zhang, L | 1 |
| Hunakova, L | 2 |
| Gronesova, P | 2 |
| Horvathova, E | 1 |
| Chalupa, I | 1 |
| Cholujova, D | 2 |
| Duraj, J | 1 |
| Sedlak, J | 3 |
| Pastorek, M | 2 |
| Simko, V | 2 |
| Takacova, M | 1 |
| Barathova, M | 1 |
| Bartosova, M | 1 |
| Sedlakova, O | 1 |
| Hudecova, S | 2 |
| Krizanova, O | 2 |
| Dequiedt, F | 1 |
| Pastorekova, S | 2 |
| Markova, J | 1 |
| Csaderova, L | 1 |
| Stracina, T | 1 |
| Sirova, M | 1 |
| Fojtu, M | 1 |
| Svastova, E | 1 |
| Novakova, M | 1 |
| Kopacek, J | 1 |
| Bryant, CS | 1 |
| Kumar, S | 1 |
| Chamala, S | 1 |
| Shah, J | 1 |
| Pal, J | 1 |
| Haider, M | 1 |
| Seward, S | 1 |
| Qazi, AM | 1 |
| Morris, R | 1 |
| Semaan, A | 1 |
| Shammas, MA | 1 |
| Steffes, C | 1 |
| Potti, RB | 1 |
| Prasad, M | 1 |
| Weaver, DW | 1 |
| Batchu, RB | 1 |
| Chen, H | 1 |
| Landen, CN | 1 |
| Li, Y | 1 |
| Alvarez, RD | 1 |
| Tollefsbol, TO | 1 |
| Chaudhuri, D | 1 |
| Orsulic, S | 1 |
| Ashok, BT | 1 |
| Chuang, LT | 1 |
| Moqattash, ST | 1 |
| Gretz, HF | 1 |
| Nezhat, F | 1 |
| Rahaman, J | 1 |
| Chiao, JW | 1 |
10 other studies available for sulforaphane and Ovarian Neoplasms
| Article | Year |
|---|---|
Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Cisplatin; DN | 2020 |
Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplat | 2018 |
Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.
Topics: Antineoplastic Agents; Catechin; Cell Proliferation; Cisplatin; Curcumin; Drug Resistance, Neoplasm; | 2019 |
Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; | 2014 |
Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.
Topics: Anticarcinogenic Agents; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxi | 2015 |
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
Topics: Animals; Anticarcinogenic Agents; Antioxidant Response Elements; Apoptosis; Calcium; Cell Line, Tumo | 2016 |
Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA | 2010 |
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Catechin; Cell Cycle; | 2013 |
Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Biomarkers; Cell Cycle; Cell Cycle Proteins; Cell Proli | 2007 |
Sulforaphane induces growth arrest and apoptosis in human ovarian cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Cell Culture Techniques; Cell Cycle; Cell Proliferati | 2007 |